TY - JOUR AU - Buzdar, A. U. AU - Ibrahim, N. K. AU - Francis, D. AU - Booser, D. J. AU - Thomas, E. S. AU - Theriault, R. L. PY - 2005 DA - 2005// TI - Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2–positive operable breast cancer JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.07.032 DO - 10.1200/JCO.2005.07.032 ID - Buzdar2005 ER - TY - JOUR AU - Romond, E. H. AU - Perez, E. A. AU - Bryant, J. AU - Suman, V. J. AU - Geyer, C. E. AU - Davidson, N. E. PY - 2005 DA - 2005// TI - Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer JO - N Engl J Med VL - 353 UR - https://doi.org/10.1056/NEJMoa052122 DO - 10.1056/NEJMoa052122 ID - Romond2005 ER - TY - JOUR AU - Tripathy, D. AU - Slamon, D. J. AU - Cobleigh, M. AU - Arnold, A. AU - Saleh, M. AU - Mortimer, J. E. PY - 2004 DA - 2004// TI - Safety of treatment of metastatic breast cancer with trastuzumab beyond disease progression JO - J Clin Oncol VL - 22 UR - https://doi.org/10.1200/JCO.2004.06.557 DO - 10.1200/JCO.2004.06.557 ID - Tripathy2004 ER - TY - JOUR AU - Sauter, G. AU - Lee, J. AU - Bartlett, J. M. AU - Slamon, D. J. AU - Press, M. F. PY - 2009 DA - 2009// TI - Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerations JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2007.14.8197 DO - 10.1200/JCO.2007.14.8197 ID - Sauter2009 ER - TY - JOUR AU - Lebeau, A. AU - Turzynski, A. AU - Braun, S. AU - Behrhof, W. AU - Fleige, B. AU - Schmitt, W. D. PY - 2010 DA - 2010// TI - Reliability of human epidermal growth factor receptor 2 immunohistochemistry in breast core needle biopsies JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.25.9366 DO - 10.1200/JCO.2009.25.9366 ID - Lebeau2010 ER - TY - JOUR AU - Xiao, C. AU - Gong, Y. AU - Han, E. Y. AU - Gonzalez-Angulo, A. M. AU - Sneige, N. PY - 2011 DA - 2011// TI - Stability of HER2-positive status in breast carcinoma: a comparison between primary and paired metastatic tumors with regard to the possible impact of intervening trastuzumab treatment JO - Ann Oncol VL - 22 UR - https://doi.org/10.1093/annonc/mdq623 DO - 10.1093/annonc/mdq623 ID - Xiao2011 ER - TY - JOUR AU - Houssami, N. AU - Macaskill, P. AU - Balleine, R. L. AU - Bilous, M. AU - Pegram, M. D. PY - 2011 DA - 2011// TI - HER2 discordance between primary breast cancer and its paired metastasis: tumor biology or test artifact? Insights through meta-analysis JO - Breast Cancer Res Treat VL - 129 UR - https://doi.org/10.1007/s10549-011-1632-x DO - 10.1007/s10549-011-1632-x ID - Houssami2011 ER - TY - JOUR AU - Robinson, M. K. AU - Doss, M. AU - Shaller, C. AU - Narayanan, D. AU - Marks, J. D. AU - Adler, L. P. PY - 2005 DA - 2005// TI - Quantitative immuno-positron emission tomography imaging of HER2-positive tumor xenografts with an iodine-124 labeled anti- HER2 diabody JO - Cancer Res VL - 65 UR - https://doi.org/10.1158/0008-5472.CAN-04-2008 DO - 10.1158/0008-5472.CAN-04-2008 ID - Robinson2005 ER - TY - JOUR AU - Dijkers, E. C. AU - Oude Munnink, T. H. AU - Kosterink, J. G. AU - Brouwers, A. H. AU - Jager, P. L. AU - Jong, J. R. PY - 2010 DA - 2010// TI - Biodistribution of 89Zr-trastuzumab and PET imaging of HER2-positive lesions in patients with metastatic breast cancer JO - Clin Pharmacol Ther VL - 87 UR - https://doi.org/10.1038/clpt.2010.12 DO - 10.1038/clpt.2010.12 ID - Dijkers2010 ER - TY - JOUR AU - Tamura, K. AU - Kurihara, H. AU - Yonemori, K. AU - Tsuda, H. AU - Suzuki, J. AU - Kono, Y. PY - 2013 DA - 2013// TI - 64Cu-DOTA-trastuzumab PET imaging in patients with HER2-positive breast cancer JO - J Nucl Med VL - 54 UR - https://doi.org/10.2967/jnumed.112.118612 DO - 10.2967/jnumed.112.118612 ID - Tamura2013 ER - TY - JOUR AU - Miller, K. D. AU - Weathers, T. AU - Haney, L. G. AU - Timmerman, R. AU - Dickler, M. AU - Shen, J. PY - 2003 DA - 2003// TI - Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on overall survival JO - Ann Oncol VL - 14 UR - https://doi.org/10.1093/annonc/mdg300 DO - 10.1093/annonc/mdg300 ID - Miller2003 ER - TY - JOUR AU - Lin, N. U. AU - Bellon, J. R. AU - Winer, E. P. PY - 2004 DA - 2004// TI - CNS metastases in breast cancer JO - J Clin Oncol VL - 22 UR - https://doi.org/10.1200/JCO.2004.01.175 DO - 10.1200/JCO.2004.01.175 ID - Lin2004 ER - TY - JOUR AU - Ono, M. AU - Ando, M. AU - Yunokawa, M. AU - Nakano, E. AU - Yonemori, K. AU - Matsumoto, K. PY - 2009 DA - 2009// TI - Brain metastases in patients who receive trastuzumab-containing chemotherapy for HER2-overexpressing metastatic breast cancer JO - Int J Clin Oncol VL - 14 UR - https://doi.org/10.1007/s10147-008-0797-8 DO - 10.1007/s10147-008-0797-8 ID - Ono2009 ER - TY - JOUR AU - Yonemori, K. AU - Tsuta, K. AU - Shimizu, C. AU - Hatanaka, Y. AU - Hashizume, K. AU - Ono, M. PY - 2008 DA - 2008// TI - Immunohistochemical profiles of brain metastases from breast cancer JO - J Neurooncol VL - 90 UR - https://doi.org/10.1007/s11060-008-9654-x DO - 10.1007/s11060-008-9654-x ID - Yonemori2008 ER - TY - JOUR AU - Leyland-Jones, B. PY - 2009 DA - 2009// TI - Human epidermal growth factor receptor 2-positive breast cancer and central nervous system metastases JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.19.8481 DO - 10.1200/JCO.2008.19.8481 ID - Leyland-Jones2009 ER - TY - JOUR AU - Steeg, P. S. AU - Camphausen, K. A. AU - Smith, Q. R. PY - 2011 DA - 2011// TI - Brain metastases as preventive and therapeutic targets JO - Nat Rev Cancer VL - 11 UR - https://doi.org/10.1038/nrc3053 DO - 10.1038/nrc3053 ID - Steeg2011 ER - TY - JOUR AU - Eichler, A. F. AU - Loeffler, J. S. PY - 2007 DA - 2007// TI - Multidisciplinary management of brain metastases JO - Oncologist VL - 12 UR - https://doi.org/10.1634/theoncologist.12-7-884 DO - 10.1634/theoncologist.12-7-884 ID - Eichler2007 ER - TY - JOUR AU - Jain, R. K. PY - 1990 DA - 1990// TI - Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors JO - Cancer Res VL - 50 ID - Jain1990 ER - TY - JOUR AU - Weinstein, J. N. AU - Eger, R. R. AU - Covell, D. G. AU - Black, C. D. AU - Mulshine, J. AU - Carrasquillo, J. A. PY - 1987 DA - 1987// TI - The pharmacology of monoclonal antibodies JO - Ann NY Acad Sci VL - 507 UR - https://doi.org/10.1111/j.1749-6632.1987.tb45802.x DO - 10.1111/j.1749-6632.1987.tb45802.x ID - Weinstein1987 ER - TY - JOUR AU - Fujimori, K. AU - Covell, D. G. AU - Fletcher, J. E. AU - Weinstein, J. N. PY - 1990 DA - 1990// TI - A modeling analysis of monoclonal antibody percolation through tumors: a binding-site barrier JO - J Nucl Med VL - 31 ID - Fujimori1990 ER - TY - JOUR AU - Stemmler, H. J. AU - Schmitt, M. AU - Willems, A. AU - Bernhard, H. AU - Harbeck, N. AU - Heinemann, V. PY - 2007 DA - 2007// TI - Ratio of trastuzumab levels in serum and cerebrospinal fluid is altered in HER2-positive breast cancer patients with brain metastases and impairment of blood–brain barrier JO - Anticancer Drugs VL - 18 UR - https://doi.org/10.1097/01.cad.0000236313.50833.ee DO - 10.1097/01.cad.0000236313.50833.ee ID - Stemmler2007 ER - TY - JOUR AU - Mehta, A. I. AU - Brufsky, A. M. AU - Sampson, J. H. PY - 2013 DA - 2013// TI - Therapeutic approaches for HER2-positive brain metastases: circumventing the blood-brain barrier JO - Cancer Treat Rev VL - 39 UR - https://doi.org/10.1016/j.ctrv.2012.05.006 DO - 10.1016/j.ctrv.2012.05.006 ID - Mehta2013 ER - TY - JOUR AU - Yonemori, K. AU - Tsuta, K. AU - Ono, M. AU - Shimizu, C. AU - Hirakawa, A. AU - Hasegawa, T. PY - 2010 DA - 2010// TI - Disruption of the blood brain barrier by brain metastases of triple-negative and basal-type breast cancer but not HER2/neu-positive breast cancer JO - Cancer VL - 116 UR - https://doi.org/10.1002/cncr.24735 DO - 10.1002/cncr.24735 ID - Yonemori2010 ER - TY - JOUR AU - Lampson, L. A. PY - 2011 DA - 2011// TI - Monoclonal antibodies in neuro-oncology: getting past the blood–brain barrier JO - MAbs VL - 3 UR - https://doi.org/10.4161/mabs.3.2.14239 DO - 10.4161/mabs.3.2.14239 ID - Lampson2011 ER - TY - JOUR AU - Muro, H. AU - Shirasawa, H. AU - Maeda, M. AU - Nakamura, S. PY - 1987 DA - 1987// TI - Fc receptors of liver sinusoidal endothelium in normal rats and humans. A histologic study with soluble immune complexes JO - Gastroenterology VL - 93 ID - Muro1987 ER - TY - JOUR AU - Mortimer, J. E. AU - Bading, J. R. AU - Colcher, D. M. AU - Conti, P. S. AU - Frankel, P. H. AU - Carroll, M. I. PY - 2014 DA - 2014// TI - Functional imaging of human epidermal growth factor receptor 2–positive metastatic breast cancer using 64Cu-DOTA-trastuzumab PET JO - J Nucl Med VL - 55 UR - https://doi.org/10.2967/jnumed.113.122630 DO - 10.2967/jnumed.113.122630 ID - Mortimer2014 ER -